Research Article
Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts
Figure 7
Ex vivo longitudinal imaging study of JIMT1 and SKOV3 xenografts. Graphic representation of GLUT1, pAkt, and pS6 at day 2 (light grey) and day 7 (dark grey) of treatment for (a, c, e) JIMT1 and (b, d, f) SKOV3 xenografts.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |